Endocrinology Diabetes and Metabolism

Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with type 2 diabetes—a condition that affects more than half a billion people worldwide.

Dr. Imperato-McGinley, who has dedicated nearly 50 years to Weill Cornell Medicine, accepted her award June 8 at a gala held in her honor.

Weill Cornell Medicine, Rutgers Cancer Institute of New Jersey and Cold Spring Harbor Laboratory have received a $25 million Cancer Grand Challenges award to tackle cancer cachexia, the debilitating wasting syndrome that is responsible for up to 30 percent of cancer-related deaths.

Dr. Laura Alonso, chief of the Division of Endocrinology, Diabetes and Metabolism and the Herbert J. and Ann L. Siegel Distinguished Professor of Medicine at Weill Cornell Medicine, has been selected to be a fellow of the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program at Drexel University College of Medicine.

Eating fructose appears to alter cells in the digestive tract in a way that enables it to take in more nutrients, according to a preclinical study from investigators at Weill Cornell Medicine and NewYork-Presbyterian. 

While diet, exercise and behavior modification are essential components of obesity management, a successful long-term weight loss strategy should also include avoiding or minimizing medication-related weight gain.